- 11.16.2023
- Updates
CBS News: U.S. military veterans turn to psychedelics in Mexico for PTSD treatment
Suicide rates for American service members and veterans are nothing short of catastrophic, with recent estimates claiming almost 17 vets take their own lives in the U.S. every day. Many of them suffer from post-traumatic stress and debilitating brain injuries, which traditional medications have largely failed to cure.
- 11.16.2023
- Updates
Stars and Stripes: Ecstasy and magic mushrooms show signs of helping with PTSD treatment, researchers say
Researchers and veterans testifying Tuesday on the use of psychedelic drugs to relieve post-traumatic stress disorder and suicidal thoughts urged House lawmakers to back more studies into the alternative treatments.
- 11.8.2023
- Updates
Newsweek: The Case for Ibogaine: Kentucky's Opportunity to Lead in the Fight Against Opioid Addiction | Opinion
As the opioid epidemic continues to grip our nation, claiming lives, destroying families, and burdening communities, it is imperative that we explore every viable solution. Among these potential solutions is a powerful, natural, non-addictive substance known as ibogaine. As voices that have served in political and military capacities, we unite in our appeal to the Kentucky Opioid Abatement Advisory Commission (KYOAAC): Allocate $42 million for ibogaine research. Kentucky has a unique chance to pioneer a revolutionary approach to combat opioid addiction and pave the way for the entire country.
- 11.3.2023
- Updates
Lucid News: An Ambitious Vision Drives Kentucky’s Ibogaine Plan to Treat Opioid Dependency
When Bryan Hubbard was appointed Executive Director of the newly formed Kentucky Opioid Abatement Advisory Commission in 2021, he had already been tracking psychedelic-assisted therapies in the media for three years.
Marijuana Moment: Veteran Access To Psychedelics Requires Balance Of Speed And Caution, Says Panel With VA And Former CDC Officials
Experts and advocates—including a Department of Veterans Affairs (VA) official and a former director of the Centers for Disease Control and Prevention (CDC)—recently convened for a Harvard University panel to discuss efforts to expand veteran access to psychedelic-assisted therapy.
Pharmacy Times: Psychedelic-Assisted Therapy Is Life-Changing for Veterans With PTSD, Yet Access to These Therapies Remain Outside the United States
Pharmacy Times interviewed Marcus Capone and Amber Capone, the co-founders of Veterans Exploring Treatment Solutions (VETS), on the current opportunities available for US veterans to seek psychedelic-assisted therapies for post-traumatic stress disorder (PTSD) and traumatic brain injuries (TBIs).
- 10.10.2023
- Updates
VETS Joins Coalition to Heal Invisible Wounds
Veterans, service members and their caregivers need better solutions for the invisible wounds of war.
Bloomberg: Toms Shoes Founder Talks Funding Plan For Psychedelics Movement
Blake Mycoskie, the founder of Toms Shoes, announced earlier this year that he’d give $100 million to support research into the medical and mental health potential of psychedelic drugs.
Matter of Fact: Veterans Say Psychedelics Are Helping Them Treat Their PTSD
After experiencing tragedy on the frontlines, veterans are looking for new ways to treat PTSD, including taking psychedelics.
KY Attorney General Daniel Cameron: Kentucky Opioid Abatement Advisory Commission Public Hearing
On Friday, September 15, 2023, VETS co-founders Marcus and Amber Capone testified for the Kentucky Opioid Abatement Advisory Commission in support of research into ibogaine as a treatment for opioid use disorder.